BeStock  
Stocks › Biotechnology › BNTX

BioNTech BNTX

US equityMarket cap rank #911BiotechnologyInfectious Disease
$80.96 −$0.42 (-0.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $81.00 +0.05%
Open$80.82
Prev close$81.38
Day range$80.27 – $82.87
Volume1.71M
Market cap$20.07B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.6x
CheapRich

Around its usual level · 44th percentile, 5-year average -5.2x

Price / book1.0x
CheapRich

Near the bottom of its 5-year range · 13th percentile, 5-year average 1.6x

#1673 of 5338 stocks by PB (1 = cheapest)

Price / sales7.6x
CheapRich

Above its usual level · 74th percentile, 5-year average 5.1x

#4384 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-88x14x116x219xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$76.00
Price vs. fair value+6.5%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.03 – 1.61 13% (cheaper than usual) #1673 of 5338 (1 = cheapest)
PE -12.55 -16.73 -5.21 44% (cheaper than usual) –
PS 7.56 12.33 5.10 74% (pricier than usual) #4384 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on BNTX.

Sign in to join the discussion.

Scroll to Top